IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q4 2019 Holdings

Filed 2020-02-14 | 12 holdings | $2.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corvus Pharmaceuticals Inc(CRVS)COM221015100$2.0M370,30793.9%
Livongo Health Inc(LVGO)COM539183103$66.1K2,636,6403.1%
Orchard Therapeutics PLCADS68570P101$40.7K2,958,4921.9%
Precision Biosciences IncCOM74019P108$12.3K882,3580.6%
Ovid Therapeutics Inc(OVID)COM690469101$3.5K843,9310.2%
Blueprint Medicines Corp(2L9)COM09627Y109$2.1K26,0000.1%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$1.6K38,5000.1%
Global Blood Therapeutics inCOM37890U108$1.6K20,0000.1%
Myokardia IncCOM62857M105$72910,0000.0%
Bluebird BIO IncCOM09609G100$7028,0000.0%
Unum Therapeutics IncCOM903214104$678940,8050.0%
Kezar Life Sciences IncCOM49372L100$619154,2550.0%